Acetaminophen
Therapeutic Efficacy in Pain and Fever Management: Acetaminophen serves as a widely utilized analgesic-antipyretic agent, recognized for its effective pain alleviation and fever reduction capabilities, establishing it as a foundational component in non-prescription analgesic products.
Stability Profile: The compound maintains chemical stability at temperatures below 45°C, preserving its pharmaceutical integrity and therapeutic effectiveness when stored under recommended cool, dry conditions.
Solubility Characteristics: Acetaminophen demonstrates significant solubility in heated aqueous solutions and ethanolic solvents, ensuring rapid dissolution for optimal bioavailability and formulation versatility.
Established Clinical History: With more than a century of documented medical application, acetaminophen possesses a well-documented safety and efficacy profile in the management of mild to moderate pain and febrile conditions
Acetaminophen, systematically named N-(4-hydroxyphenyl)acetamide and commercially designated as paracetamol, is classified among acetanilide-derived antipyretic analgesics. First synthesized by Morse in 1878, its initial clinical application was documented by Von Mering in 1893. The compound achieved over-the-counter approval in the United States in 1955, with Chinese domestic production initiated during the late 1950s according to Chemicalbook documentation.
Melting point | 168-172 °C(lit.) |
Boiling point | 273.17°C (rough estimate) |
density | 1,293 g/cm3 |
vapor pressure | 0.008Pa at 25℃ |
refractive index | 1.5810 (rough estimate) |
Fp | 11 °C |
storage temp. | Inert atmosphere,Room Temperature |
solubility | ethanol: soluble0.5M, clear, colorless |
form | Crystals or Crystalline Powder |
pka | 9.86±0.13(Predicted) |
color | White |
PH Range | 5.5 - 6.5 (H?O, 20 °C) (saturated solution) |
PH | 5.5-6.5 (H2O, 20℃)(saturated solution) |
Odor | odorless |
explosive limit | 15%(V) |
Water Solubility | 14 g/L (20 ºC) |
Merck | 14,47 |
BRN | 2208089 |
BCS Class | 3,4 |
InChIKey | RZVAJINKPMORJF-UHFFFAOYSA-N |
LogP | 1.098 at 25℃ |
CAS DataBase Reference | 103-90-2(CAS DataBase Reference) |
NIST Chemistry Reference | Acetaminophen(103-90-2) |
IARC | 3 (Vol. 50, 73) 1999 |
EPA Substance Registry System | Acetaminophen (103-90-2) |
Safety Information | |
Hazard Codes | Xn,T,F |
Risk Statements | 22-36/37/38-52/53-36/38-40-39/23/24/25-23/24/25-11 |
Safety Statements | 26-36-61-37/39-22-45-36/37-16-7 |
RIDADR | UN 3077 9/PG III |
WGK Germany | 1 |
RTECS | AE4200000 |
Autoignition Temperature | 540 °C |
TSCA | Yes |
HazardClass | 9 |
PackingGroup | III |
HS Code | 29242930 |
Hazardous Substances Data | 103-90-2(Hazardous Substances Data) |
Toxicity | LD50 in mice (mg/kg): 338 orally (Starmer), 500 i.p. (Dahlin, Nelson |
The compound maintains chemical stability at temperatures below 45°C. Under humid environmental conditions, however, it undergoes hydrolytic degradation to yield p-aminophenol, which subsequently undergoes oxidative transformation. This degradation pathway is visually identifiable through progressive chromatic transition from pinkish hue to brown coloration, ultimately developing black pigmentation. Therefore, optimal preservation requires maintenance in cool, desiccated storage environments.
This pharmaceutical substance manifests as white crystalline structures or powdered crystals, exhibiting a characteristic melting point between 168-172°C. It is characterized by absence of odor and a mildly bitter taste profile, demonstrating high solubility in heated aqueous and ethanolic solutions, moderate dissolution in acetone, and negligible solubility in both cold aqueous media and petroleum ether.






